Partex NV

Partex NV is a pioneering digital pharma platform that operates as an 'AI-powered Drug Assets Manager.' The company specializes in identifying, in-licensing, and de-risking 'off-strategy' or deprioritized drug assets from major pharmaceutical companies. By leveraging its proprietary AI arm, Innoplexus, Partex uses advanced machine learning to identify new indications, optimize clinical pathways, and enrich asset dossiers to accelerate the path to market. The company operates through a decentralized structure with specialized subsidiaries such as Oncoteq (Oncology) and Cureteq (Asset Management). Partex aims to solve inefficiencies in the life sciences industry by transforming the traditional drug development model into a capital-efficient 'Asset-as-a-Service' ecosystem, bridging the gap between early-stage innovation and commercial success.